Novo Nordisk: Clinical Trials & FDA Approval Profile
Novo Nordisk (Bagsvaerd, DK / Plainsboro, NJ) sponsors 176 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 60 active protocols (31 recruiting now), 104 completed protocols, and 20 all-time original FDA Drugs@FDA NDA and BLA approvals.